Sonnet BioTherapeutics
Jul
14
2025
Sonnet BioTherapeutics to merge with Rorschach I LLC in a $888 million deal
0 Comments
Nasdaq-listed biotech firm Sonnet BioTherapeutics announced Monday… More…
Read More